7 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has grown 19.3% per year over the past 5 years.
Operating margin has contracted, at -7.6% in the latest year.
Free cash flow has declined 41.7% per year over the past 5 years.
Financial health
Total debt ($56M) exceeds cash ($8M); net debt is $48M.
Total debt has grown slower than revenue (11.5% vs 19.3% per year).
Operating income covered interest expense -1.9× in the latest year.
Total debt is 46× EBITDA.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
2025
$152M
-$12M
0.0%
-7.6%
$692000
$56M
$8M
2024
$180M
-$8M
0.0%
-0.9%
-$3M
$70M
$8M
2023
$196M
-$4M
0.0%
5.0%
$14M
$72M
$10M
2022
$169M
-$15M
0.0%
-2.7%
$12M
$84M
$10M
2021
$133M
$11M
0.0%
11.8%
$20M
$83M
$25M
2020
$63M
$8M
0.0%
16.0%
$10M
$33M
$10M
2019
$41M
-$2M
0.0%
1.6%
$499000
—
—
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
Mar '26
$39M
-$2M
0.0%
-4.6%
$5M
$45M
$17M
Dec '25
$33M
$1M
0.0%
-3.0%
-$3M
$56M
$8M
Sep '25
$35M
-$10M
0.0%
-27.9%
-$405000
$57M
$5M
Jun '25
$44M
-$591000
0.0%
1.8%
$5M
$58M
$8M
Mar '25
$39M
-$3M
0.0%
-4.0%
-$1M
$69M
$6M
Dec '24
$39M
-$5M
0.0%
-9.9%
-$815000
$70M
$8M
Sep '24
$43M
-$6M
0.0%
-8.7%
-$3M
$70M
$6M
Jun '24
$51M
-$3M
0.0%
-9.8%
-$576000
$71M
$10M
Mar '24
$48M
$6M
0.0%
23.1%
$2M
$71M
$11M
Dec '23
$48M
-$5M
0.0%
2.9%
$3M
$72M
$10M
Sep '23
$47M
-$2M
0.0%
2.0%
-$1M
$73M
$9M
Jun '23
$56M
$2M
0.0%
9.6%
$10M
$83M
$21M
Mar '23
$46M
-$14000
0.0%
3.8%
$2M
$83M
$11M
Dec '22
$41M
-$7M
0.0%
-14.6%
$4M
$84M
$10M
Sep '22
$39M
-$7M
0.0%
-3.5%
-$4M
$82M
$8M
Jun '22
$50M
$583000
0.0%
8.0%
$9M
$83M
$35M
Mar '22
$40M
-$693000
0.0%
-3.0%
$3M
$83M
$27M
Dec '21
$38M
-$393000
0.0%
-32.6%
-$8M
$83M
$25M
Sep '21
$35M
$8M
0.0%
27.8%
$7M
—
$10
Jun '21
$35M
$10M
0.0%
32.0%
$13M
—
—
Valuation over time
How the market has priced AIRS against its own fundamentals since 2023-03 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-sales ratio has fallen from 2.1× (Mar '23) to 2.0× (Jun '26).
The dividend yield has fallen from 6.5% (Mar '23) to 0.1% (Nov '25).
Price / sales (P/S)
P/S
Dividend yield (%)
Dividend yield %
Frequently asked questions
Is AIRS growing its revenue and profit?
Over the past 5 years, Airsculpt Technologies, Inc.'s revenue has grown 19.3% per year. These are computed facts, not advice.
How much debt does AIRS have?
As of FY2025, Airsculpt Technologies, Inc. reported $56M of total debt against $8M of cash; operating income covered interest expense -1.9×.
What is AIRS's profit margin?
In FY2025, gross margin was —, operating margin -7.6%, and net margin -7.7%.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.